SEC Form 4 · accession 0001193125-26-396868
Black Diamond Therapeutics, Inc. · BDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ali Behbahani
Director
Period of report
Sep 18, 2026
Accepted (ET)
Sep 21, 2026 · 5:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001701541
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 18, 2026 | A | 7,707 | $1.93 | A | 110,236 | D | |
| Common StockF3 | holding | — | — | — | 4,448,757 | I | See Note 3 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were issued in accordance with the Issuer's Sixth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- F2The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 17, 2026.
- F3The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.